APA (7th ed.) Citation

Hillmen, P., Szer, J., Weitz, I., Röth, A., Höchsmann, B., Panse, J., . . . de la Tour, R. P. (2021). Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria. The New England journal of medicine, 384(11), 1028-1037. https://doi.org/10.1056/NEJMoa2029073

Chicago Style (17th ed.) Citation

Hillmen, Peter, et al. "Pegcetacoplan Versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria." The New England Journal of Medicine 384, no. 11 (2021): 1028-1037. https://doi.org/10.1056/NEJMoa2029073.

MLA (9th ed.) Citation

Hillmen, Peter, et al. "Pegcetacoplan Versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria." The New England Journal of Medicine, vol. 384, no. 11, 2021, pp. 1028-1037, https://doi.org/10.1056/NEJMoa2029073.